Featuring an interview with Prof Philippe Moreau, including the following topics:
- Perspectives on efficacy outcomes with and toxicity profiles of daratumumab and isatuximab (0:00)
- Selection of an anti-CD38 antibody for initial treatment of multiple myeloma (MM) (7:28)
- Approach to maintenance therapy for transplant-eligible patients with MM (15:47)
- Management of MM in older patients; treatment approaches for t(11;14) MM (22:47)
- Management of relapsed/refractory MM (29:49)
- Management of anti-CD38 antibody-associated side effects (35:45)
- Other relevant clinical scenarios in MM — Plasma cell leukemia, smoldering myeloma (41:19)
- Perspectives on the future landscape of up-front treatment for MM (45:02)
CME information and select publications
Research To Practice | Oncology Videos